Toronto-based cannabis investment firm Sol Global Investments has completed a nonbrokered private placement financing of common shares of its international hemp subsidiary, Heavenly Rx,... Sol Global subsidiary closes $12 million round of private financing

Toronto-based cannabis investment firm Sol Global Investments has completed a nonbrokered private placement financing of common shares of its international hemp subsidiary, Heavenly Rx, for more than $12 million.

As a result, Sol Global now holds 34.4% of Heavenly Rx’s shares, while the rest of the common shares were sold to accredited investors for 10 cents each.

Heavenly Rx will use proceeds from the offering to acquire significant or controlling ownership interests in various hemp, CBD and THC-free cannabis wellness businesses.

Also based in Toronto, Heavenly Rx will focus primarily on hemp cultivation, processing and manufacturing of traditional CBD products, including oils, tinctures, balms, and vape-ready products.

Sol Global made another hemp acquisition in March, purchasing a majority stake in Knoxville, Tennessee-based biomass processing and extraction company Bluhen Botanicals through a $30.6 million investment from Heavenly Rx.

Sol Global Investments trades on the Canadian Securities Exchange as SOL and on over-the-counter markets as SOLCF.

Subscribe to our Newsletter

MJ Shareholders avatar

MJ Shareholders

MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers

No comments so far.

Be first to leave comment below.




( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )